Clinical investigation of medicinal products in the treatment of depression

  • Email
  • Help
Current effective version

Revision 2 - Adopted guideline

Reference numberCHMP/185423/2010 Rev. 2
Effective from01/12/2013
KeywordsMajor depression, major depressive episode, partial response, treatment resistance, suicidal thoughts, suicidal behaviour, suicide, acute treatment, maintenance treatment, recurrence prevention
DescriptionThis document provides guidance on the development of medicinal products for acute and long-term treatment of major depressive disorder

Document history

Revision 3

In progress

Concept paper

Published: 18/11/2016

Deadline for comments: 28/02/2017

Revision 2 

Current version

Adopted guideline

Draft guideline

Concept paper

In operation: 01/12/2013–present

Published: 11/10/2011

Published: 19/02/2009

Revision 1 Adopted guidelineIn operation: 01/10/2002–30/11/2013

Related content

How helpful is this page?

Average rating:

 Based on 25 ratings

Add your rating:

See all ratings
5 ratings
5 ratings
5 ratings
5 ratings
5 ratings

Tell us more